ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
New Drug for Gastrointestinal Stromal Tumours (GIST) to be Launched in Australia, New Zealand and South East Asia Following Distribution Agreement
November 06, 2020A NEW therapy to treat advanced gastrointestinal stromal tumours (GIST) will be available to patients in Australia, New Zealand and in some parts of South East Asia, following an exclusive distribution agreement. -
Deciphera gets FDA nod for Qinlock to treat fourth-line gastrointestinal stromal tumour
May 20, 2020Deciphera Pharmaceuticals has secured approval from the US Food and Drug Administration (FDA) for its Qinlock (ripretinib) to treat fourth-line gastrointestinal stromal tumour (GIST).
Pharma Sources Insight January 2025
